Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$382,839,306
+$58,378,808 QoQ
Shares Held
1,521,377
+2.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#102
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $5,015,687,266 across 13 Drug Manufacturers - General names. ABBV ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,536,227 | $1,429,019,361 | |
| 2 | LLY |
ELI LILLY & Co
|
1,001,608 | $1,201,358,780 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,938,774 | $497,624,704 | |
| 4 | JNJ |
Johnson & Johnson
|
1,657,928 | $421,063,972 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,521,377 | $382,839,306 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,581,691 | $331,747,292 | |
| 7 | AMGN |
Amgen Inc
|
821,365 | $297,432,693 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,327,511 | $249,351,182 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $382,839,306 | 1,521,377 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $324,460,498 | 1,491,841 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $396,666,407 | 1,736,034 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $112,765,767 | 487,025 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $62,749,769 | 338,055 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $116,880,940 | 557,851 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $189,149,744 | 1,064,433 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $173,565,172 | 878,900 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $126,673,008 | 738,532 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $189,647,498 | 1,041,447 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $97,402,829 | 628,527 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $87,485,102 | 586,912 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $88,510,469 | 656,947 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $66,570,283 | 417,709 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $91,224,319 | 564,472 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $65,571,650 | 488,575 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $93,906,070 | 613,124 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $76,110,645 | 469,500 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $56,655,828 | 418,433 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $63,724,741 | 590,755 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $40,415,794 | 358,805 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $40,382,833 | 373,155 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $39,021,457 | 364,176 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $25,200,605 | 287,711 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $39,069,159 | 397,934 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $27,463,599 | 360,462 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||